Molecular Endocrinology, Vol 10, 286-297, Copyright © 1996 by Endocrine Society

ARTICLES

Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells

MJ Ellis, BA Leav, Z Yang, A Rasmussen, A Pearce, JA Zweibel, ME Lippman and KJ Cullen
Vincent T Lombardi Cancer Center, Georgetown University Medical Center, Washington, D.C, USA.

We have investigated the autocrine regulation of insulin-like growth factor-II (IGF-II) signaling by the insulin-like growth factor-I receptor (IGF-IR) and the insulin-like growth factor-II/mannose 6- phosphate receptor (IGF-IIR) in MCF-7 breast cancer cells, employing retroviruses encoding both IGF-I, IGF-II, and IGF-I and II mutants with reductions in affinity for either the IGF-IR or the IGF-IIR. These studies revealed reciprocal roles for IGF-IR and IGF-IIR affinity in the regulation of autocrine IGF-II activity. IGF-IR affinity was required for serum-free proliferation but also for efficient IGF-II secretion. In contrast, cellular proliferation, receptor tyrosine kinase-dependent signaling, and extracellular IGF-II protein accumulation were all reduced in the presence of IGF-IIR affinity. Inhibition of IGF-II signaling appeared to be the sole consequence of IGF-IIR affinity, as no cellular responses attributable to selective IGF-IIR binding by a reduced IGF-IR affinity IGF-II mutant could be detected. By operating as an IGF-II antagonist, the IGF-IIR has tumor suppressor-like properties, a suggestion consistent with reports of loss of heterozygosity at the IGF-IIR locus in a variety of human malignancies.

This article has been cited by other articles:

				L.J. Spicer and P.Y. Aad Insulin-Like Growth Factor (IGF) 2 Stimulates Steroidogenesis and Mitosis of Bovine Granulosa Cells Through the IGF1 Receptor: Role of Follicle-Stimulating Hormone and IGF2 Receptor Biol Reprod, July 1, 2007; 77(1): 18 - 27. [Abstract] [Full Text] [PDF]

				K. L. Gable, B. A. Maddux, C. Penaranda, M. Zavodovskaya, M. J. Campbell, M. Lobo, L. Robinson, S. Schow, J. A. Kerner, I. D. Goldfine, et al. Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth. Mol. Cancer Ther., April 1, 2006; 5(4): 1079 - 1086. [Abstract] [Full Text] [PDF]

				C. F. Singer, M. Mogg, W. Koestler, M. Pacher, E. Marton, E. Kubista, and M. Schreiber Insulin-Like Growth Factor (IGF)-I and IGF-II Serum Concentrations in Patients with Benign and Malignant Breast Lesions: Free IGF-II Is Correlated with Breast Cancer Size Clin. Cancer Res., June 15, 2004; 10(12): 4003 - 4009. [Abstract] [Full Text] [PDF]

				T. McKinnon, C. Chakraborty, L. M. Gleeson, P. Chidiac, and P. K. Lala Stimulation of Human Extravillous Trophoblast Migration by IGF-II Is Mediated by IGF Type 2 Receptor Involving Inhibitory G Protein(s) and Phosphorylation of MAPK J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3665 - 3674. [Abstract] [Full Text] [PDF]

				D. Chambery, S. Mohseni-Zadeh, B. d. Galle, and S. Babajko N-myc Regulation of Type I Insulin-like Growth Factor Receptor in a Human Neuroblastoma Cell Line Cancer Res., June 1, 1999; 59(12): 2898 - 2902. [Abstract] [Full Text] [PDF]

				S. Zaina, R. V. S. Newton, M. R. Paul, and C. F. Graham Local Reduction of Organ Size in Transgenic Mice Expressing a Soluble Insulin-Like Growth Factor II/Mannose-6-Phosphate Receptor Endocrinology, September 1, 1998; 139(9): 3886 - 3895. [Abstract] [Full Text] [PDF]

				R. Clark The Somatogenic Hormones and Insulin-Like Growth Factor-1: Stimulators of Lymphopoiesis and Immune Function Endocr. Rev., April 1, 1997; 18(2): 157 - 179. [Abstract] [Full Text]